Make ANKTIVA available in the U.S
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 23 Apr 2024
- Due
- 31 May 2024
- Delivered
- May 2024
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“ANKTIVA is expected to be available in the U.S. by mid-May 2024”
What we found
Evidence strength A What the grades mean
ImmunityBio confirmed that ANKTIVA became commercially available in the U.S. in May 2024, meeting the company's commitment to make the product available by mid-May 2024.
-
A ImmunityBio, Inc. 10-Q filed 2024-08-12
“Our approved product became available in May 2024” ✓ confirmed on the page
-
A ImmunityBio, Inc. 10-K filed 2025-03-03
“We began commercial distribution of our approved product in May 2024.” ✓ confirmed on the page
Market reaction: the shares moved -16.6% against the S&P 500 over the three sessions around the disclosure (9 Aug 2024 to 14 Aug 2024). What this measures
Checked 1 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Product other
- Indicative materiality
- Low rules
- Action
- Make
- Deliverable
- ANKTIVA availability
- Where
- U.S.
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you ImmunityBio, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2024-IBRX-002819 · Corrections policy